Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty

Journal of Gastrointestinal Surgery

Volumn 11, Issue 12, 2007, Pages 1692-1698

  Binion, David G ^a   Theriot, Kenneth R ^a   Shidham, Sushrut ^a   Lundeen, Sarah ^a   Hatoum, Ossama ^a   Lim, Hyun J ^a   Otterson, Mary F ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

6 Mercaptopurine; Adhesions; Azathioprine; Complications; Crohn's disease; Infliximab; Methotrexate; Strictureplasty; Surgery

Indexed keywords

ADULT; ARTICLE; CROHN DISEASE; FEMALE; HUMAN; LAPAROTOMY; MALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REOPERATION; RETROSPECTIVE STUDY; SMALL INTESTINE; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; HUMANS; INTESTINE, SMALL; LAPAROTOMY; MALE; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 36148994753     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0298-5     Document Type: Article

References (33)

1. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National cooperative Crohn's disease study: Factors determining recurrence of Crohn's disease after surgery. Gastroenterology 1979;77:907-913.
2. Whelan G, Farmer RG, Fazio VW, Goormastic M. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985;88:1826-1833.
3. Sachar DB, Subramani K, Mauer K, Rivera-MacMurray S, Turtel P, Bodian C, Greenstein AJ. Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease: A retrospective cohort study of 71 patients. J Clin Gastroenterol 1996;22:114-116.
4. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38-45.
5. DeDombal FT, Burton I, Goligher JC. The early and late results of surgical treatment for Crohn's disease. Br J Surg 1971;58:805-816.
6. D'Haens G, Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflamm Bowel Dis 1999;5:295-303.
7. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-267.
8. Krupnick AS, Morris JB. The long-term results of resection and multiple resections in Crohn's disease. Semin Gastrointest Dis 2000;11:41-51.
9. Heimann TM, Greenstein AJ, Lewis B, Kaufman D, Heimann DM, Aufses AH Jr. Comparison of primary and reoperative surgery in patients with Crohns disease. Ann Surg 1998;227:492-495.
10. Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, Milsom JW, Strong SA, Oakley JR, Secic M. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996;224:563-571; discussion 571-573.
11. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-267.
12. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991;214:230-238; discussion 238-240.
13. Lock MR, Farmer RG, Fazio VW, Jagelman DG, Lavery IC, Weakley FL. Recurrence and reoperation for Crohn's disease: the role of disease location in prognosis. N Engl J Med 1981;304:1586-1588.
14. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:674-678.
15. Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000;342:1627-1632.
16. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-1549.
17. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-713.
18. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996;91:1571-1578.
19. Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG. Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. J Clin Gastroenterol 2003;37:125-128.
20. Stein RB, Lichtenstein GR. Medical therapy for Crohn's disease: the state of the art. Surg Clin North Am 2001;81:71-101, viii.
21. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-1035.
22. Rutgeerts PJ, Targan SR. Introduction: anti-TNF strategies in the treatment of Crohn's disease. Aliment Pharmacol Ther 1999;13(Suppl 4):1.
23. Yamamoto T, Keighley MR. Factors affecting the incidence of postoperative septic complications and recurrence after strictureplasty for jejunoileal Crohn's disease. Am J Surg 1999;178:240-245.
24. Dietz DW, Laureti S, Strong SA, Hull TL, Church J, Remzi FH, Lavery IC, Fazio VW. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease. J Am Coll Surg 2001;192:330-337; discussion 337-338.
25. Broering DC, Eisenberger CF, Koch A, Bloechle C, Knoefel WT, Durig M, Raedler A, Izbicki JR. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. Int J Colorectal Dis 2001;16:81-87.
26. Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD. Strictureplasty for Crohn's disease: meta-analysis. Dis Colon Rectum 2000;43:911-919.
27. Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003;134:565-572; discussion 572-573.
28. Colombel JF, Loftus EV Jr., Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004;99:878-883.
29. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-729.
30. Resegotti A, Astegiano M, Farina EC, Ciccone G, Avagnina G, Giustetto A, Campra D, Fronda GR. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery. Dis Colon Rectum 2005;48:464-468.
31. Scarpa M, Angriman I, Barollo M, Polese L, Ruffolo C, Bertin M, D'Amico DF. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease. Hepatogastroenterology 2004;51:1053-1057.
32. Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand J Gastroenterol 1999;34:708-713.
33. Otterson MF, Lundeen SJ, Spinelli KS, Sudakoff GS, Telford GL, Hatoum OA, Saeian K, Yun H, Binion DG. Radiographic underestimation of small bowel stricturing Crohn's disease: a comparison with surgical findings. Surgery 2004;136:854-860.